Undermining Apices in Surgical Wounds
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Feb 24, 2023
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Reducing scar tissue formation and postoperative complications in wound closure has remained the focus of recent studies and decreases the cost and time burden of follow-up visits and procedures. Such studies have highlighted the impact of mechanical forces and tension on scar formation, demonstrating that reducing the mechanical stress within the wound environment results in better aesthetic outcomes. Undermining peripheral and apices of the wound has been used in the closure of large and tight defects allowing the closure of these wounds by reducing the tension. Undermining has been shown...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Able to give informed consent themselves
- • Patient scheduled for cutaneous surgical procedure on the neck, trunk, and extremities with predicted primary closure
- • Willing to return for follow-up visit
- Exclusion Criteria:
- • Incarceration
- • Under 18 years of age
- • Pregnant women
- • Unable to understand written and oral English
- • Wounds with predicted closure length less than 3cm
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Daniel Eisen, MD
Principal Investigator
University of California, Davis - Dermatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials